Skip to main content

Closed

ACTU: Actuate Therapeutics Inc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-521.2%

Financially safe

Stretched

Debt / equity0.11×

Interest coverage-1078.3×

Current ratio1.80×

Actuate Therapeutics Inc

ACTUNASDAQ Global Market·USD·Closed

Actuate Therapeutics Inc

ACTUNASDAQ·USD·Closed

$1.11

−5.13%

$1.11

−$0.06 (5.13%)

52W Range

1thpctl

Volume

0.62×avg

Mkt Cap

26.56MUSD

P/E

-1.1TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.62×avg

Market Cap

26.56MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings